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BACKGROUND: In sub-Saharan Africa umbilical cord
blood may be a useful source of blood for transfusion.
Before clinical trials, evidence is needed that cord blood
donations, which vary greatly in volume, can be col-
lected and stored into a fixed volume of anticoagulant-
preservative solution obviating the need for prestorage
processing.
STUDY DESIGN AND METHODS: Twenty-four umbili-
cal cord whole blood (UC-WB) donations were collected
into 21 mL of CPDA-1 and refrigerated for 35 days. The
Kenya Blood Transfusion Service provided 12 adult-
donated whole blood (AD-WB) controls. Supernatant
hemoglobin (Hb) and potassium were assayed at 7-day
intervals.
RESULTS: UC-WB red blood cell hemolysis and potas-
sium loss increased throughout storage but did not
differ significantly with cord blood volume. Hemolysis
rates did not differ significantly between UC-WB and
AD-WB but UC-WB potassium loss was slightly but sig-
nificantly greater than AD-WB on Days 2, 7, and 14
(p < 0.05). In the AD-WB controls, eight were low
volume (<405 mL), two had total Hb of less than 45 g,
and two showed hemolysis greater than 0.8% by
Day 28.
CONCLUSION: Variable volumes of UC-WB can be
stored for 35 days without prestorage processing and
further work into its suitability for transfusion to children
is justified. The quality of conventional AD-WB is a
concern and needs further evaluation.
I
n industrialized countries, stored autologous umbili-
cal cord red blood cells (RBCs) have been infused
back to neonates who require a transfusion because
of surgery or anemia of prematurity. 1-3 Allogeneic
cord blood transfusion in older children and adults has also
been reported.4,5 In developing countries, where conven-
tional blood supplies are severely limited but the demand
for transfusions in young children is high, allogeneic cord
blood may be a useful supplement to the blood supply if
operational feasibility and safety can be demonstrated.6,7
We have previously published data relating to acceptability
and consent8 and a large study to assess microbiologic
safety including the risk of bacterial contamination is
under way. Here we report on the quality of umbilical cord
RBCs collected and stored as whole blood in a fixed volume
of anticoagulant-preservative (AP) solution.
ABBREVIATIONS: AD-WB = adult-donated whole blood;
AP = anticoagulant-preservative; RBTC = Regional Blood Trans-
fusion Centre; UC-WB = umbilical cord whole blood.
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Cord blood is most simply collected by venipuncture
of a suspended umbilical cord so that the blood flows by
gravity into a collection bag prefilled with a fixed volume
of AP solution. This is analogous to the manner in which
a conventional adult blood donation is collected. Cord
blood collection volumes rarely exceed 150 mL, so the col-
lection bags are smaller than those for adult blood dona-
tions of 450 mL. The fixed volume of AP solution with
which the collection bag is prefilled is also reduced, so that
the blood-to-AP ratio is optimal for 150 mL of cord blood
and no greater (21 mL of AP solution; 7:1 ratio). However,
cord blood collection volumes are variable and are usually
much less than 150 mL (mean, 64-86 mL2-4,7,9) and there-
fore the cord blood–to-AP ratio is also variable and usually
higher than is considered optimal.
In industrialized countries, when cord blood has been
transfused, this issue has been negated by prestorage pro-
cessing of whole cord blood into RBCs by differential cen-
trifugation, component separation into satellite bags, and
the addition of an additive solution in a fixed ratio to the
concentrated RBC fraction.10 However, the bag configura-
tion, laboratory equipment, and expertise required to do
this are technically and financially prohibitive for devel-
oping countries where most blood is stored and trans-
fused as whole blood.11 In these countries the transfusion
of cord blood is only likely to be feasible if it can be stored
as whole blood without prestorage processing.
The purpose of this study therefore was to investigate
the storage characteristics of whole cord blood collected
into a fixed volume of AP solution under local conditions.
We were unable to find published data on the storage of
conventional adult-donated whole blood (AD-WB) in a
resource-limited setting, and so concomitant adult whole
blood controls were used for comparison. The primary
RBC storage lesions investigated were hemolysis and
intracellular potassium loss as indicated by supernatant
potassium levels.
MATERIALS AND METHODS
Sample size and unit selection
The study took place from February to April in 2007 in
Mombasa, Kenya. Three units of AD-WB from each of one
static and three mobile donation sessions were provided
by the Regional Blood Transfusion Centre (RBTC; total of
12 units). No instruction was given about which units
from a particular session were to be entered into the study,
although it was known that the study was looking at
quality and storage issues. Twenty-four consecutive
umbilical cord whole blood (UC-WB) donations with a
minimum volume of 40 mL were used in the study.
Collection technique and storage conditions
The RBTC staff collected AD-WB units according to their
standard operating procedures: blood donations were
collected into single bags designed for a standard 450 mL
(10%) collection and prefilled with 63 mL of CPDA-1
(Medibag; Eastern Medikit Ltd, India); predonation
screening of donor hemoglobin (Hb) was performed using
the copper sulfate method (specific gravity 1.053, corre-
sponding to a Hb of 12.5 g/dL), and the volume of blood
collected was monitored at the time of collection using a
spring balance.
UC-WB was collected after delivery of the placenta
from consenting mothers delivering at term on the labor
ward of Coast Provincial General Hospital, Mombasa. The
placenta was placed fetal side down on the absorbent
surface of an incontinence pad, which was clipped over a
metal hoop. The hoop was attached to a metal rod like a
retort stand and the clamped umbilical cord passed
through a hole cut into the middle of the incontinence
pad. The hoop was raised up (and with it the placenta) and
clamped higher up the stand such that the cord hung
down with its full length suspended and the umbilical
cord vein filled with blood by gravity.
The entire cord was disinfected twice with 70% iso-
propyl alcohol and then the intended venipuncture site,
which is at the distal end of the cord just above where it is
clamped, swabbed with 2% povidone iodine tincture.
Cord blood was collected by a single venipuncture of the
umbilical vein with the 16-gauge needle of a 250-mL
single blood collection bag containing 21 mL of CPDA-1
(Macopharma, Twickenham, UK) and drainage of the cord
blood into the bag by gravity. Universal precautions and
attention to asepsis were observed throughout the
procedure.
Screening of all units for human immunodeficiency
virus, hepatitis B and C, and syphilis was performed by the
RBTC laboratory using their standard methods. In the case
of cord blood, a maternal sample taken around the time of
delivery was tested. AD-WB and UC-WB units were stored
in the same refrigerator at a temperature of 2 to 6°C for 35
days. In the event of main power supply failure, the refrig-
erator was connected to the hospital diesel generator. The
refrigerator temperature was monitored manually twice
a day.
Sampling of blood packs
All blood packs were sampled on Days 2, 7, 14, 21, 28, and
35 after collection (day of collection is Day 1). They were
removed from the refrigerator and rocked gently by hand
in a plastic tray for 10 minutes to resuspend the cellular
components. To reduce the risk of bacterial contamina-
tion, which can cause hemolysis, blood packs were
sampled on Days 2, 7, 14, and 21 in the following manner:
the blood in the pilot tube was stripped back into the main
pack three times using a tube stripper, the tubing was
clipped twice 15 cm from the distal end of the tube and
then cut between the two clips, the two cut ends were
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rinsed with 70% methanol and the blood pack was placed
back in the refrigerator, and the 1 to 2 mL of blood in the
removed tube segment was then transferred into a plain
test tube.
On Day 28, when pilot tube lengths were too short for
the sampling method described above, a sterile spiked
sampling coupler (Baxter, Newbury, UK) was inserted
aseptically in a laminar flow hood into one of the ports on
each pack, and a sample was withdrawn through this. The
coupler was left in place and the Day 35 samples were
obtained in the same manner.
Laboratory assays
Unit weights were established by weighing on a tared
scale before sampling on Day 2. Hemograms were per-
formed on all samples with an automated cell counter
(Nihon Kohden Corp., Shinjuku-ku, Japan). Samples were
centrifuged at 3000 ¥ g for 5 minutes (Heraeus Instru-
ments, Hanau, Germany) and the supernatant was trans-
ferred with a pipette to a different tube, which was
centrifuged at 3000 ¥ g for an additional 5 minutes.
Supernatant (plasma) Hb was assayed with a plasma/low
Hb photometer (Hemocue, Angelholm, Sweden) and
then the remainder of the supernatant was stored at
-20°C. The supernatant (plasma) potassium con-
centration was assayed at a later date on the thawed
plasma samples (Instrumentation Laboratory, Lexington,
MA).
Calculated values and statistical analysis
Donation volumes were estimated by subtracting the
CPDA-1 volume from the unit weight and multiplying by
1.06. 12 Supernatant Hb (g/dL), total Hb (g/dL), and hema-
tocrit (Hct) were used to calculate percentage hemolysis
according to the formula
Supernatant Hb Hct Total Hb× −( )[ ]100 .
To adjust for the dilution effect of excess CPDA-1 in
smaller donations, supernatant potassium concentra-
tions (supernatant K, mmol/L) were standardized by
donation volume (L) by estimating the total potassium
and dividing by donation volume as follows:
Supernatant K Hct Donation volume× −( )[ ]100 .
All data were entered into an electronic database and
analyzed using statistical software (Stata v9.2, StataCorp,
College Station, TX). AD-WB variables were assumed to
have a normal distribution and summarized by the mean
and standard deviation (SD). The 24 UC-WB donations
were ranked according to donation volume and allocated
to six equal groups (Table 2). Nonparametric statistics were
used to summarize these data and to test for the signifi-
cance of observed differences between cord blood groups
(Kruskal-Wallis) and between adult-donated and cord
blood (Wilcoxon rank sum). Binary data were expressed as
proportions and observed differences compared for statis-
tical significance with the chi-squared test of association.
RESULTS
Summary baseline (Day 2) characteristics of the 12
AD-WB units are shown in Table 1. Mean donation
volume was 387 mL with 8 of the 12 units having a dona-
tion volume of less than 405 mL. There was a wide varia-
tion in unit Hb concentration (8.6-13.4 g/dL) and total
unit Hb content (35-67 g); 2 of the 12 units contained less
than 45 g of Hb.
Cord blood donation volume ranged from 42 to
128 mL and the ratio of blood to CPDA-1 from 2.0 to 6.1
(Table 2). RBC, Hct, and Hb values for UC-WB all
increased with donation volume as the dilution effect of
the CPDA-1 was reduced (Table 2), as did supernatant
potassium concentration (Table 3).
Hemolysis increased throughout the storage period in
both AD-WB and UC-WB, reaching median values on Day
35 of 0.61 and 0.57%, respectively (Table 3). There was no
significant difference in the median hemolysis rates of
cord blood when analyzed by volume or between AD-WB
and UC-WB, at any of the sampling points. On Day 28
hemolysis of greater than 0.8% was evident in 2 of the 24
UC-WB units (8%) and 2 of the 12 AD-WB units (17%). An
additional 4 UC-WB units showed hemolysis of greater
than 0.8% on Day 35. The proportion of units in each
group with hemolysis exceeding 0.8% was not significant
on either Day 28 or Day 35, but the study had negligible
power to detect such differences.
When total supernatant potassium was standardized
by donation volume, there was no significant difference
between cord blood groups. However, standardized potas-
sium was consistently higher in UC-WB than AD-WB and
this was to a significant degree on Days 2, 7, and 14.
TABLE 1. Summary baseline characteristics of 12 AD-WB units (63 mL of CPDA-1)
Unit volume
(mL)
Donation
volume (mL)
Blood : CPDA
ratio (mL)
RBCs
(¥106/mL)
Hct
(%)
Hb concentration
(g/dL)
Total
Hb (g)
Mean (SD) 450 (29) 387 (29) 6.1 (0.5) 4.07 (0.61) 31.6 (3.5) 11.0 (1.2) 50 (8)
Range 404-498 341-435 5.4-6.9 3.12-5.02 24.5-36.3 8.6-13.4 35-67
UMBILICAL CORD BLOOD STORAGE IN KENYA
Volume 50, March 2010 TRANSFUSION 613
DISCUSSION
This study assessed the storage characteristics of a wide
range of volumes of UC-WB collected into a fixed volume
of CPDA-1 (21 mL) and refrigerated for 35 days in a
resource-limited setting. The findings suggest RBC sur-
vival and function, as demonstrated by hemolysis and
intracellular potassium loss, are comparable with AD-WB
stored under the same conditions and that UC-WB can be
stored without difficult and expensive prestorage process-
ing. Cord blood collected and stored in this manner may
not be transfused to small children as whole blood if there
is a risk of citrate toxicity from a large volume of CPDA-1.
However, simpler options for RBC concentration and
volume reduction using gravity separation are possible
immediately before transfusion when the integrity of a
single collection bag can be breached with less risk of
bacterial proliferation.13,14
The increases in hemolysis and supernatant potas-
sium concentration with duration of storage shown here
for UC-WB are consistent with previous data,9,15 our own
AD-WB controls, and international norms for whole blood
stored in CPDA-1 for 35 days.12 Significantly, however, we
also show no significant difference in hemolysis rates
or adjusted supernatant potassium concentrations for
UC-WB over a wide range of cord blood volumes. Previous
studies of cord blood collected into fixed volumes of AP
solution have not been stratified and analyzed by dona-
tion volume in this way.
Our data also demonstrated no significant difference
in the hemolysis rates of UC-WB RBCs compared with
AD-WB controls at any time point. This is in contrast to
cord blood stored as RBCs in extended storage medium,
which show significantly higher hemolysis rates at the end
of storage (35 days) compared with conventional RBCs.10
The higher adjusted supernatant potassium concen-
trations seen in UC-WB suggest greater intracellular
potassium loss from UC-WB RBCs and may indicate a
difference in the function of the sodium/potassium
adenosine triphosphatase pump in UC-WB RBCs during
storage.12 However, the difference in supernatant potas-
sium concentrations is not significant after Day 14, the
Day 35 levels are comparable to international norms for
AD-WB, and intracellular potassium levels are expected to
replenish after transfusion.
This study did not investigate other markers of RBC
storage such as RBC ATP, reduced glutathione and 2,3-
diphosphoglycerate, and osmotic fragility. Previous
studies suggest that given the degree of RBC viability dem-
onstrated here, these variables are likely to be within an
acceptable range and/or reversible after transfusion.9,15,16
Further work, however, needs to be done and ultimately
cord blood RBC survival should be assessed in vivo with
clinical trials comparing clinical and hematologic vari-
ables before and after cord blood transfusion. Clinical
studies in children involving radiolabeled cord blood
RBCs would present ethical and practical difficulties in
sub-Saharan Africa.
TABLE 2. Baseline characteristics of 24 UC-WB donations with stratification by donation volume (see text)
Group
allocation
Unit
volume (mL)
Donation
volume (mL)
Blood : CPDA
ratio
RBC
(¥106/mL)
Hct
(%)
Hb concentration
(g/dL)
Total
Hb (g)
1 63 42 2.0 2.96 27.0 9.5 5.9
64 43 2.1 2.78 27.0 9.5 6.1
64 43 2.1 2.45 25.8 8.8 5.7
76 55 2.6 3.03 26.9 8.9 6.7
2 79 58 2.8 3.27 32.3 11.4 9.1
79 58 2.8 3.01 32.2 11.4 9.1
81 60 2.9 3.88 37.6 12.9 10.5
81 60 2.9 2.77 27.8 9.9 8.1
3 85 64 3.1 3.4 31.9 11.1 9.5
91 70 3.3 3.78 35.5 12.1 11.0
91 70 3.3 4.21 36.8 12.2 11.1
93 72 3.4 3.38 31.4 10.8 10.0
4 93 72 3.4 3.64 34.7 12.1 11.2
98 77 3.7 2.78 31.2 10.8 10.6
98 77 3.7 3.98 37.2 13.1 12.9
98 77 3.7 3.5 33.9 11.5 11.3
5 100 79 3.8 3.68 38.7 14.0 14.0
102 81 3.9 2.86 29.9 10.3 10.5
104 83 4.0 3.36 33.2 11.8 12.3
106 85 4.0 3.34 34.8 12.2 12.9
6 106 85 4.0 4.4 39.9 13.9 14.7
123 102 4.9 4.34 33.5 11.5 14.1
129 108 5.1 4.23 34.9 11.7 15.0
149 128 6.1 3.28 33.5 11.8 17.6
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It is noteworthy that after 35 days of storage a propor-
tion of both UC-WB and AD-WB units showed levels of
hemolysis higher than international quality standard of
0.8%.17 In addition, two-thirds of the AD-WB units
provided to the study by the RBTC were below the recom-
mended lower volume limit of 405 mL and were not
labeled as such.17 This, combined with the likelihood that
some donor Hb concentrations were probably less than
12.5 g/dL, resulted in an almost twofold range in total unit
Hb and 2 units having a total Hb of less than the interna-
tional standard of 45 g.17 This has implications for pediat-
ric clinical practice, which assumes minimum Hb content
for transfused blood and is therefore prescribed using a
volume multiplier (20 mL/kg18). The AD-WB unit with the
lowest Hb content in this study would provide 30% less
oxygen-carrying capacity than the average (1.6 g/kg vs.
2.2 g/kg). This may result in poor clinical outcome and/or
exposure to further transfusions and raises issues about
quality checks, training, and supervision with regard to
donor Hb screening and blood collection within the Kenya
Blood Transfusion Service.
In conclusion, the findings of this study support the
collection of variable volumes of umbilical cord blood into
a fixed volume of CPDA-1 and its subsequent refrigerated
storage for up to 35 days. This provides further evidence of
the feasibility and safety of cord blood RBC transfusion in
children with severe anemia in resource-restricted coun-
tries. Further work on microbiologic and clinical safety is
either planned or under way.
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